Author Correction: Targeting public neoantigens for cancer immunotherapy

被引：0
|
作者：
Alexander H. Pearlman
Michael S. Hwang
Maximilian F. Konig
Emily Han-Chung Hsiue
Jacqueline Douglass
Sarah R. DiNapoli
Brian J. Mog
Chetan Bettegowda
Drew M. Pardoll
Sandra B. Gabelli
Nicholas Papadopoulos
Kenneth W. Kinzler
Bert Vogelstein
Shibin Zhou
机构：
[1] The Johns Hopkins University School of Medicine,Ludwig Center, Sidney Kimmel Comprehensive Cancer Center
[2] The Johns Hopkins University School of Medicine,Lustgarten Pancreatic Cancer Research Laboratory, Sidney Kimmel Comprehensive Cancer Center
[3] Howard Hughes Medical Institute,Division of Rheumatology, Department of Medicine
[4] The Johns Hopkins University School of Medicine,Department of Biomedical Engineering
[5] Johns Hopkins University,Department of Neurosurgery
[6] The Johns Hopkins University School of Medicine,Department of Oncology
[7] The Johns Hopkins University School of Medicine,Bloomberg~Kimmel Institute for Cancer Immunotherapy
[8] Sidney Kimmel Comprehensive Cancer Center,Department of Biophysics and Biophysical Chemistry
[9] The Johns Hopkins University School of Medicine,Department of Medicine
[10] The Johns Hopkins University School of Medicine,Department of Pathology
[11] The Johns Hopkins University School of Medicine,Sol Goldman Pancreatic Cancer Research Center
[12] The Johns Hopkins University School of Medicine,undefined
[13] Genentech,undefined
[14] Inc.,undefined
来源：
Nature Cancer | 2021年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：865 / 867
页数：2
相关论文
共 50 条
  • [31] Identification and validation of shared neoantigens for cancer immunotherapy
    Busby, Jennifer
    Rotunno, Melissa
    Murphy, Tyler
    Brinton, William
    Zhong, Michael
    Kim, Lina
    Jalloh, Abu
    Costa, Amanda
    Fray, Michael
    Yang, Aaron
    Hart, Meghan
    Davis, Matthew
    Zhou, Rita
    Maloney, Elizabeth
    Mantila, Alexis
    Jooss, Karin
    Nowicka, Aleksandra
    Palmer, Christine
    Sun, James
    Yelensky, Roman
    Busby, Jennifer
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [32] Targeting Neoantigens in Cancer: Possibilities and Opportunities in Breast Cancer
    Chaudhry, Zuhair
    Boyadzhyan, Anik
    Sasaninia, Kayvan
    Rai, Vikrant
    ANTIBODIES, 2024, 13 (02)
  • [33] Glycans in cancer immunoediting: Glycosylated neoantigens as target for cancer immunotherapy
    Silva, Mariana
    Ruano, Dina
    Vicente, Manuel
    Bulk Van den, Jitske
    Miranda de, Noel F. C. C.
    Pinho, Salome S.
    GLYCOBIOLOGY, 2021, 31 (12) : 1685 - 1685
  • [34] Tumor neoantigens: Novel strategies for application of cancer immunotherapy
    Guan, Hanyang
    Wu, Yue
    Li, Lu
    Yang, Yabing
    Qiu, Shenghui
    Zhao, Zhan
    Chu, Xiaodong
    He, Jiashuai
    Chen, Zuyang
    Zhang, Yiran
    Ding, Hui
    Pan, Jinghua
    Pan, Yunlong
    ONCOLOGY RESEARCH, 2023, 31 (04) : 437 - 448
  • [35] Targeting neoantigens
    Nick Bernard
    Nature Immunology, 2022, 23 : 1399 - 1399
  • [36] New emerging targets in cancer immunotherapy: the role of neoantigens
    De Mattos-Arruda, Leticia
    Blanco-Heredia, Juan
    Aguilar-Gurrieri, Carmen
    Carrillo, Jorge
    Blanco, Julia
    ESMO OPEN, 2019, 4
  • [37] Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets
    Chen, Chao
    Liu, Songming
    Qu, Ruokai
    Li, Bo
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [38] Gene fusion neoantigens: Emerging targets for cancer immunotherapy
    Wang, Yue
    Shi, Tao
    Song, Xueru
    Liu, Baorui
    Wei, Jia
    CANCER LETTERS, 2021, 506 : 45 - 54
  • [39] Neoantigens in cancer immunotherapy: quantity vs. quality
    Wolf, Yochai
    Sameuls, Yardena
    MOLECULAR ONCOLOGY, 2023, 17 (08) : 1457 - 1459
  • [40] Immune targets and neoantigens for cancer immunotherapy and precision medicine
    Wang, Rong-Fu
    Wang, Helen Y.
    CELL RESEARCH, 2017, 27 (01) : 11 - 37
12345